| Literature DB >> 27570552 |
Hongyang Yi1, Zhuyao Wang1, Xiaojiao Li1, Min Yin2, Lihua Wang2, Ali Aldalbahi3, Nahed Nasser El-Sayed3, Hui Wang1, Nan Chen2, Chunhai Fan2, Haiyun Song1.
Abstract
Many types of biocompatible nanomaterials have proven of low cytotoxicity and hold great promise for various applications in nanomedicine. Whereas they generally do not cause apparent organ toxicity or tissue damage in adult animals, it is yet to determine their biological consequences in more general contexts. In this study, we investigate how silica nanoparticles (NPs) affect cellular activities and functions under several physiological or pathological conditions. Although silica NPs are generally regarded as "inert" nanocarriers and widely employed in biomedical studies, we find that they actively affect Wnt signaling in various types of cell lines, diminishing its anti-adipogenic effect in preadipocytes and pro-invasive effect in breast cancer cells, and more significantly, impair Wnt-regulated embryonic development in Zebrafish. We further demonstrate that intracellular silica NPs block Wnt signal transduction in a way resembling signaling molecules. Specifically, silica NPs target the Dvl protein, a key component of Wnt signaling cascade, for lysosomal degradation. As Wnt signaling play significant roles in embryonic development and adipogenesis, the observed physiological effects beyond toxicity imply potential risk of obesity, or developmental defects in somitogenesis and osteogenesis upon exposure to silica NPs. In addition, given the clinical implications of Wnt signaling in tumorigenesis and cancer metastasis, our work also establishes for the first time a molecular link between nanomaterials and the Wnt signaling pathway, which opens new door for novel applications of unmodified silica NPs in targeted therapy for cancers and other critical illness.Entities:
Keywords: cancer metastasis; embryonic development; obesity; signal transduction; silica nanoparticles
Mesh:
Substances:
Year: 2016 PMID: 27570552 PMCID: PMC4997238 DOI: 10.7150/thno.16127
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556